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Cortical development depends on the active integra-
tion of cell-autonomous and extrinsic cues, but the
coordination of these processes is poorly under-
stood. Here, we show that the apical complex protein
Pals1 and Pten have opposing roles in localizing the
Igf1R to the apical, ventricular domain of cerebral
cortical progenitor cells. We found that the cerebro-
spinal fluid (CSF), which contacts this apical domain,
has an age-dependent effect on proliferation, much
of which is attributable to Igf2, but that CSF contains
other signaling activities as well. CSF samples from
patients with glioblastomamultiforme show elevated
Igf2 and stimulate stem cell proliferation in an Igf2-
dependent manner. Together, our findings demon-
strate that the apical complex couples intrinsic and
extrinsic signaling, enabling progenitors to sense
and respond appropriately to diffusible CSF-borne
signals distributed widely throughout the brain. The
temporal control of CSF composition may have crit-
ical relevance to normal development and neuro-
pathological conditions.
INTRODUCTION
Neural development involves a dynamic interplay between cell
autonomous and diffusible extracellular signals that regulate
symmetric and asymmetric division of progenitor cells
(Johansson et al., 2010). In mammalian neural progenitors,
homologs of C. elegans and Drosophila polarity proteins,including Par3 (partitioning defective protein 3) and Pals1
(protein associated with Lin 7), assemble as apical complexes
that play essential roles in regulating self-renewal and cell fate
(Margolis and Borg, 2005). The unequal distribution of apical
surface components during mitosis is a key determinant of
daughter cell fate in C. elegans and Drosophila (Fishell and
Kriegstein, 2003; Kemphues, 2000; Siller and Doe, 2009; Wo-
darz, 2005). Recently, mammalian Par3 was shown to promote
asymmetric cell division by specifying differential Notch
signaling in radial glial daughter cells (Bultje et al., 2009), sug-
gesting that the inheritance of the apical complex guides progen-
itor responses to proliferative signals as well.
Secreted signals can act at a distance to guide decisions gov-
erning progenitor proliferation and cell fate (Johansson et al.,
2010), but little is known of how secreted signals interact
with cell-autonomous ones. Insulin-like growth factor 1 (Igf1)
promotes progenitor proliferation (Hodge et al., 2004;
Popken et al., 2004). Insulin/Igf1 signaling is regulated by E-cat-
enin in keratinocytes (Vasioukhin et al., 2001) and b-catenin in
oligodendrocyte progenitors (Ye et al., 2010), suggesting that
cell polarity proteins govern cellular responses to extrinsic cues.
Direct interactions between Par3 and Pten (phosphatase and
tensin homolog) (Feng et al., 2008; Pinal et al., 2006; von Stein
et al., 2005; Wu et al., 2007) suggest that the apical complex
interacts with growth factor signaling pathways. Indeed, disrupt-
ing the apical complex via Pals1 leads to attenuated pS6
signaling, premature cell cycle exit, and rapid cell death, result-
ing in the absence of nearly the entire cerebral cortex (Kim et al.,
2010). In turn, Pals1-deficiency can be partially rescued by
concomitant activation of mTOR (mammalian target of rapamy-
cin) (Kim et al., 2010), a downstream effector of growth factor
signaling. Growth factor signaling, in particular via the type 1
Igf receptor (Igf1R), mediates powerful, age-dependent effects
on the development and maintenance of many organ systemsNeuron 69, 893–905, March 10, 2011 ª2011 Elsevier Inc. 893
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The CSF Instructs Cortical Progenitor Proliferationincluding the brain through the regulation of progenitor cell divi-
sion (Baker et al., 1993; Hodge et al., 2004; Liu et al., 2009;
Popken et al., 2004; Randhawa and Cohen, 2005). Nevertheless,
the mechanisms coordinating the availability of Igf ligands to
cortical progenitor cells have remained unclear.
Though vascular sources of secreted proliferative signals are
well characterized (Palmer et al., 2000; Shen et al., 2004, 2008;
Tavazoie et al., 2008), the apical surfaces of early cortical precur-
sors and their primary cilia do not approximate blood vessels but
instead directly contact the cerebrospinal fluid (CSF) (Fuchs and
Schwark, 2004; Kim et al., 2010), suggesting that secreted
factors may interact with progenitor cells at this interface. The
CSF proteome shows a complex and dynamic pattern of protein
expression (Dziegielewska et al., 1981; Parada et al., 2005;
Zappaterra et al., 2007), suggesting important roles beyond
provision of a fluid cushion for the central nervous system and
maintenance of extracellular ionic balance. The CSF has recently
been implicated in carrying secreted proteins in several
contexts, including Fgf2 to midbrain progenitors (Martı´n et al.,
2006), Sonic hedgehog to cerebellar progenitors (Huang et al.,
2010) and Slit guidance of neuroblasts in adult brain (Sawamoto
et al., 2006). Regulation of cerebral cortical progenitor cells by
growth factors distributed in the lateral ventricular CSF would
provide potentially global control over cerebral cortical neuro-
genesis, but this hypothesis has not been examined.
Here, we show that the apical complex couples autonomous
regulation of progenitor proliferation to CSF-borne signals in
the developing cerebral cortex. Pals1 and Pten interact geneti-
cally to regulate cerebral cortical size and progenitor proliferation
and have opposing roles in localizing the Igf1R to the apical
domain of cortical progenitors. Apically localized Igf1Rs respond
to CSF-borne Igf ligands, particularly Igf2, and CSF regulates
cortical progenitor proliferation in an Igf2-dependent fashion.
Finally, CSF Igf2 concentration is elevated in patients with malig-
nant glioblastoma, suggesting that CSF proteins may regulate
CNS tumorigenesis. Our findings suggest that the apical
complex couples autonomous and extrinsic signaling in cerebral
cortical progenitors, enabling these cells to respond appropri-
ately to diffusible CSF-borne signals that regulate cortical neural
stem cells during development and disease.
RESULTS
Genetic Interactions of Pals1 and Pten
at the Apical Surface Region
Since Pals1 loss disrupts growth factor signaling and cortical
development (Kim et al., 2010), we looked for potential interac-
tions of Pals1 with other regulators of growth factor signaling
and found genetic interactions between Pals1 and Pten (Groszer
et al., 2001). Cerebral cortex-specific deletion of Pals1 was
achieved by crossing mice with a conditional Pals1 allele
(Pals1loxP/loxP) (Kim et al., 2010) with mice carrying Emx1-
promoter-driven Cre recombinase (Emx1Cre+/) (Gorski et al.,
2002). Pals1loxP/loxP/Emx1Cre+/ mice lacked nearly the entire
cortical structure due to premature cell cycle exit and cell death
(Kim et al., 2010), with heterozygotes having an intermediate
phenotype (Figure 1A). In contrast, Pten deficiency, obtained
by crossing PtenloxP/loxP mice (Groszer et al., 2001) with either894 Neuron 69, 893–905, March 10, 2011 ª2011 Elsevier Inc.Emx1Cre+/ or NestinCre+/ mice, resulted in cortical hyper-
plasia arising from excessive and extended proliferation of apical
progenitors (Figure 1A; see Figures S1A–S1E available online;
Groszer et al., 2001). While the broadest groupings of cells
were preserved in Pten mutants, the cortical plate was disorga-
nized across its entire radial extent (Figures S1A–S1C). No
phenotypic abnormalities were observed in either heterozygous
PtenloxP/+/NestinCre+/ mice or in PtenloxP/loxP/NestinCre/
littermate controls (Figure S1A and data not shown). Conditional
deletion of Pten in the Pals1loxP/+/Emx1Cre+/ mice resulted in
an almost normal cortical size (Figure 1A). Histological analyses
of Pals1loxP/+/Emx1Cre+/ mice or PtenloxP/+/Pals1loxP/+/
Emx1Cre+/ mice revealed a severely disrupted laminar organi-
zation of the dorsomedial cortex (Figure 1B; Kim et al., 2010).
Double mutants showed a relatively normal organization of the
marginal zone (Figure 1B), consistent with a genetic interaction
between the apical complex and Pten. The expression of apical
complex components, especially Cdc42, were abnormal in Pten
cortex (Figure S1F and data not shown). The proportion of prolif-
erative progenitor cells marked by Ki67-positive staining cells
was greater in the doublemutant cortex compared to conditional
Pals1 heterozygotes (Figure 1C) and brain size was also
more normal by embryonic day (E) 14.5 (Figures S1G and S1H).
Proportions of early-born neurons marked by Tbr1 and
Ctip2 were also more normal in the PtenloxP/loxP/
Pals1loxP/+/Emx1Cre+/mice than in either Pals1 or Ptenmutants
alone (Figure 1D and data not shown). However, cells in the
double mutant brain appeared irregular in size and lamination
(Figure 1D), a finding consistent with roles for Pten in the regula-
tion of cell size and polarity (Figure S1C; Chalhoub et al., 2009;
Groszer et al., 2001) and with a role for Pten downstream of
the apical complex.
The genetic interaction between Pals1 and Pten and the
decreased proliferation of progenitors and prominent cell death
in Pals1 mutants (Kim et al., 2010) prompted us to test whether
the apical complex interacts with Igf signaling, since Igfs play
a prominent role in cell cycle kinetics of cortical progenitors,
cell survival, and brain size (Hodge et al., 2004; Liu et al., 2009;
Popken et al., 2004; Schubert et al., 2003). The Igf1R, which
binds both Igf1 and Igf2, mediates the proliferative response to
Igf signaling (Weber et al., 1992). Surprisingly, Igf1R was en-
riched in cortical progenitors at the apical, ventricular surface,
interdigitating with b-catenin (Figures 2A–2D), suggesting the
apical region as the likely site for binding of Igf1R ligand. Apical
Igf1R expression was strikingly decreased in Pals1loxP/loxP/
Emx1Cre+/ mice (Figure 2E). By contrast in the absence of
Pten, Igf1R immunoreactivity demonstrated a considerable ba-
solateral spread in clusters of radial glia (Figure 2F and data
not shown). Analyses of downstream signaling events, using a
specific antibody against the phosphorylated form of Rsk
substrate S6 ribosomal protein (phospho-S6rp), revealed an
apical pattern of activity within control brains (Figure 2G). In
contrast in Pten mutants, phospho-S6rp showed a broad distri-
bution across the cortical tissue, with many robust phospho-
S6rp-positive cells extending basally away from the lateral
ventricle (Figure 2G). While the majority of cells positive for
Igf1R were clearly apical progenitors, some upregulation of
Igf1R in basal progenitors is possible. Though we cannot rule
Figure 1. The Apical Complex and Pten
Modulate Brain Size
(A) Conditional Pten deletion (PtenloxP/loxP/
Pals1+/+Emx1Cre+/) resulted in hyperplasia and
an enlarged cerebral cortex. Ablation of Pten in
PtenloxP/loxP/Pals1loxP/+/Emx1Cre+/ mice largely
restored the small brain phenotype of PtenloxP/+/
Pals1loxP/+/Emx1Cre+/ neonates.
(B) H&E staining of PtenloxP/+/Pals1loxP/+/
Emx1Cre/, PtenloxP/+/Pals1loxP/+/Emx1Cre+/,
and PtenloxP/loxP/Pals1loxP/+/Emx1Cre+/ neo-
nates. Arrowheads point to marginal zone.
(C) The proportion of Ki67-positive staining
progenitors was restored in the E14.5
PtenloxP/loxP/Pals1loxP/+/Emx1Cre+/ cortex
compared to PtenloxP/+/Pals1loxP/+/Emx1Cre+/
(percent Ki67-positive staining cells ± SEM;
PtenloxP/+/Pals1loxP/+/Emx1Cre/, 65.6 ± 2.3;
PtenloxP/+/Pals1loxP/+/Emx1Cre+/, 58.4 ± 2.0;
PtenloxP/loxP/Pals1loxP/+/Emx1Cre+/, 75.8 ± 0.4;
ANOVA, p < 0.01, n = 3).
(D) Left panels: representative images of
Ctip2-positive and Tbr1-positive staining
neurons analyzed in PtenloxP/+/Pals1loxP/+/
Emx1Cre/, PtenloxP/+/Pals1loxP/+/Emx1Cre+/,
and PtenloxP/loxP/Pals1loxP/+/Emx1Cre+/ neo-
nates. Right panels: the cortical plate was
subdivided into six equal bins and Ctip2 and
Tbr1 positive cells quantified per bin are ex-
pressed as percent of total cells per bin. Pten
deletion in thePtenloxP/loxP/Pals1loxP/+/Emx1Cre+/
mice restored the proportions of early-born cells
marked by Tbr1 and Ctip2 (percent positive stain-
ing cells/total: PtenloxP/+/Pals1loxP/+/Emx1Cre/
Ctip2 = 8.13 ± 2.0, Tbr1 = 38.7 ± 2.4; PtenloxP/+/
Pals1loxP/+/Emx1Cre+/ Ctip2 = 1.6 ± 1.2, Tbr1 =
18.8 ± 3.1; PtenloxP/loxP/Pals1loxP/+/Emx1Cre+/
Ctip2 = 8.5 ± 1.6, Tbr1 = 39.1 ± 2.6; ANOVA,
p < 0.05, n = 3).
See also Figure S1.
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Igf signaling and cortical growth, we interpret our data to suggest
that within the cortical ventricular zone, Pals1 and Pten spatially
restrict IgfR expression and Igf signaling to the apical membrane
domain.
Loss and gain of Igf signaling in mutant mice produced pheno-
types similar to those seen when apical complex signaling is
disrupted. Mice with Igf1R deficiency limited to neural precur-
sors (Igf1RloxP/loxP/NestinCre+/) were microcephalic (Fig-
ure 2H–2J; Kappeler et al., 2008; Liu et al., 2009) and had
a reduced frequency of phospho-Histone H3 (PH3, a marker of
cell division) proliferative progenitors in the ventricular zone
(PH3-positive cells/100 mm VZ ± SEM at E16.5: control, 2.9 ±
0.3; Igf1RloxP/loxP/NestinCre+/, 1.7 ± 0.1; unpaired t test, p <
0.01; n = 4 and n = 3, respectively). We did not observe differ-
ences in progenitor cell survival at the ventricular zone in these
mice as assessed by cleaved caspase 3 (CC3) immunoreactivity
(data not shown). Conversely, mice with increased Igf activity(Igf1 expressed from the humanGFAP promoter) were macroce-
phalic (data not shown) (Ye et al., 2004) and had increased prolif-
erative progenitors at the ventricular surface (PH3-positive cells/
100 mm VZ ± SEM at E18.5: control, 0.9 ± 0.08; Igf1_Tg, 1.2 ±
0.07; unpaired t test, p < 0.05, n = 3 and n = 4, respectively).
Together with published work demonstrating that Insulin
receptor substrate 2 (Irs2) deletion leads to microcephaly
(Schubert et al., 2003), these data suggest that Igf signaling in
cortical progenitors, facilitated at the apical surface via Pals1
and an intact apical complex, regulates cortical development.
CSF-Borne Igf Signaling
The normal apical localization of the Igf1R, and the fact that we
did not observe Igf1 or Igf2 mRNA in neural progenitor cells by
in situ hybridization (Figures 3A, 3B, and data not shown; Ayer-le
Lievre et al., 1991), suggested that progenitor cells may be
exposed to Igfs derived from the lateral ventricle CSF. We
confirmed the presence of Igf2 in an unbiased tandem massNeuron 69, 893–905, March 10, 2011 ª2011 Elsevier Inc. 895
Figure 2. Igf1R Expression in Cortical Progenitor Cells
(A) Left panel: Igf1R in situ hybridization at E14.5 mouse. Right panel: high-magnification image of area denoted in left panel.
(B) Igf1R enriched along the ventricular surface of E17 rat cortex.
(C) Confocal images of Igf1Rb and b-catenin immunostaining in rat E17 ventricular zone.
(D) En face view of the mouse E16.5 ventricular zone immunostained with Igf1Rb and b-catenin.
(E) Ventricular Igf1R expression was disrupted in E12.5 Pals1loxP/loxP/Emx1Cre+/ cortex.
(F) Left panel: Igf1R expression was enriched along the apical, ventricular zone of E14.5 PtenloxP/+/NestinCre+/ controls. Right panel: Igf1R expression expanded
basolaterally in PtenloxP/loxP/NestinCre+/ radial glia.
(G) Left panel: pS6rp activity along the ventricular progenitors of E14.5 PtenloxP/+/NestinCre+/ controls. Right panel: pS6rp localization extended basolaterally
in PtenloxP/loxP/NestinCre+/ radial glia. See also Figure S1.
(H) Igf1R deficiency in NestinCre expressing cells diminished brain size at E16.5.
(I) Brain weights of Igf1RloxP/loxP/NestinCre+/ and controls at E16.5 (brain weight (g) ± SEM: Igf1RloxP/loxP/NestinCre+/: 0.06; Igf1RloxP/loxP/NestinCre+/:
0.03 ± 0.001; n = 2 [+/+], n = 3 [/]).
(J) H&E staining of brains shown in (H).
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The CSF Instructs Cortical Progenitor Proliferationspectrometry (LC-MS/MS) analysis of CSF (Table S1; Binoux
et al., 1986) and detected Igf1 in CSF by ELISA (E14 CSF
[Igf1], 72.2 ng/ml, n = 2; E17 CSF [Igf1], 69.6 ng/ml; adult
CSF [Igf1], 68.8 ng/ml, n = 3). Igf1 expression in the CSF re-
mained stable across the ages sampled (see above). In contrast,
expression of Igf2 in rat CSF was temporally dynamic; it peaked
during periods of neurogenesis and declined in adulthood (Fig-
ure 3C). High levels of Igf2 mRNA expression by the choroid
plexus suggested this as a source of CSF Igf2 (Figure 3B), and
quantitative PCR revealed that rat choroid plexus expressed
10.7-fold more Igf2 than its cortical counterpart at E17 (data
not shown). We confirmed that Igf2 mRNA was also expressed
in vascular endothelial cells, and leptomeninges in the rat
embryo at E14 and E17 as well as pericytes at E17 (Figures
3A, 3B, and data not shown; Bondy et al., 1992; Dugas et al.,
2008; Stylianopoulou et al., 1988), suggesting that extrachoroi-896 Neuron 69, 893–905, March 10, 2011 ª2011 Elsevier Inc.dal sources of Igf2 may contribute to CSF-Igf2 content as well.
Immunogold labeling revealed Igf2 binding to progenitors along
the apical, ventricular surface (Figure 3D). Moreover, Igf2 binding
to progenitors was highly enriched along primary cilia (Figure 3E),
which extend directly into the ventricular space (Figure 3F;
Cohen et al., 1988). We did not observe enriched Igf2 binding
beyond the apical surface of ventricular zone progenitor cells
(data not shown). Thus, the robust expression of Igf2 by the
choroid plexus and the apical binding of Igf2 to progenitors along
the ventricular zone strongly suggest that the CSF distributes
choroid plexus secreted Igf2 to cortical progenitor cells.
Purified rat E17 CSF directly stimulated Igf1R mediated
signaling activity, reflected by Igf1Rb phosphorylation as well
as phosphorylation of Akt and MAPK (Figure 3G), two down-
stream targets of Igf signaling as well as other growth factors
that may be present in CSF. Igf2 treatment by itself induced Igf
Figure 3. Igf2 Is Expressed in Cerebrospinal Fluid
and Stimulates Progenitor Proliferation
(A and B) Igf2 in situ hybridization of rat E14 and E17
cortex. Arrow points to choroid plexus.
(C) Transient Igf2 expression in rat CSF.
(D) Immunogold labeling of endogenous Igf2 in E17 rat
brain. Left panel: no primary control. Right panel: Igf2
binding to ventricular surface of cortical progenitors. Scale
bar represents 500 nm.
(E) Igf2 binding to primary cilium of cortical progenitor cell.
Arrow points to ciliary basal body. Scale bar represents
500 nm.
(F) Scanning EM of mouse ventricular surface at E12.5.
Arrowheads point to primary cilia projecting into the
ventricular space. Scale bar represents 2 mm.
(G) Lysates of cortical cells deprived of growth factors for
6 hr and treatedwith ACSF, E17CSF, or Igf2 for 5minwere
immunoblotted with antibodies to P-Igf1R, P-Akt, Akt,
P-ERK1/2, and ERK1/2.
(H) Schematic of cortical explant dissections: explant
placed on membrane with ventricular side down contact-
ing CSF and notch making medial-caudal side.
(I) Left panel: E16 explants cultured with NBM plus 20%
ACSF (control) or with supplemental Igf2 immunostained
with anti-Vimentin 4A4 and Hoechst represented as
mean ± SEM (Igf2 mean, 36.7 ± 2.1; control mean, 20.4 ±
4.46; n = 8; Mann-Whitney; p < 0.005). Vimentin 4A4-
positive cells increased in explants cultured with Igf2
compared to control. Right panels: representative images
of explants quantified in left panels.
(J) Single cells dissociated from primary neurospheres
cultured in control media or control media containing
Igf2 (20 ng/ml). Igf2 stimulated secondary sphere forma-
tion after 10 DIV (Igf2 mean, 39.3 ± 4.1; control mean,
2.2 ± 0.75; n = 3; t test; p < 0.005).
See also Table S1.
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progenitors, the localization of the Igf1R, its phosphorylation,
as well as the phosphorylation of its downstream targets Akt
and MAPK in response to CSF, strongly suggest that the CSF
is a primary source of Igf ligands for cerebral cortical neuroepi-
thelial cells, although additional sources cannot be completely
excluded.
We next tested whether Igf2 supports progenitor proliferation
in a cerebral cortical explant system. In this system, rat embry-
onic cortex dissected from the lateral pallium is placed on
polycarbonate membranes and floated on defined media (Fig-
ure 3H). We found that Igf2 added to neurobasal medium
(NBM) with 20% artificial CSF (ACSF) stimulated the prolifera-
tion of progenitor cells marked by phospho-Vimentin 4A4 in
rat cortical explants (Figure 3I; Noctor et al., 2002). In addition,
Igf2 treatment alone maintained GLAST-positive neurospheres,
an in vitro model of neural stem cells, even in the absence of
Fgf2 (fibroblast growth factor 2) and Egf (epidermal growth
factor) (Figure 3J; Vescovi et al., 1993). Finally, pharmacologic
activation of the signaling pathway with insulin demonstrated
that activation of Igf signaling by ligands other than Igf2 is
sufficient to stimulate proliferation (PH3-positive cells/100 mm
VZ ± SEM in E16 rat explant: control mean, 5.6 ± 0.7; insulin
(10 mg/ml) mean, 11.2 ± 0.4; Mann-Whitney, p < 0.05; n = 6).
Therefore, Igf signaling modulates proliferation of isolatedcortical precursors or those maintained in their pallial environ-
ment in vitro.
CSF Promotes Proliferation of Progenitor Cells
in an Age-Dependent Manner
Since the CSF is a complex fluid containing many factors
including Igf binding proteins that may modulate Igf2 bioavail-
ability and signaling (Figures 4A and 4B; Table S1; Clemmons,
1997; Zappaterra et al., 2007), we tested whether native CSF
alone could support cortical tissue growth. We used a hetero-
chronic ‘‘mix-and-match’’ approach for exposing cortical tissue
to CSF collected at different ages. E16 rat cortical explants with
intact meninges and vasculature cultured with 100% E17 rat
CSF for 24 hr, without any additional exogenous media or
factors, retained remarkable tissue architecture, cell viability,
and proliferation, approximating in vivo E17 rat cortex (Fig-
ure 4C). In contrast, E16 explants cultured with 100% artificial
CSF failed to thrive, had decreased mitotic activity, disorganized
neuronal morphology, and increased cell death (Figures 4C,
S2A, and S2B). Filtration analysis of E17 CSF showed that the
sizes of CSF factors that support stem cells likely range from
10 kDa–100 kDa, suggesting that they are proteins (Table S2
and data not shown). Thus, the embryonic CSF proteome
provides essential growth and survival factors for the developing
cortex.Neuron 69, 893–905, March 10, 2011 ª2011 Elsevier Inc. 897
Figure 4. Embryonic CSF Supports Cortical
Explant Viability and Stimulates Prolifera-
tion of Neural Progenitor Cells
(A) TotalCSFprotein concentration over thecourse
of rat development.
(B) Silver stain of embryonic rat CSF revealed
a dynamic fluid with numerous changes in
protein composition over time. Asterisks indicate
proteins with varying CSF expression during
development.
(C) E17 rat cortex and E16 explants grown for
24 hr in 100% embryonic E17 CSF or 100%
artificial CSF, respectively. Upper panels: anti-
PH3 (red), and anti-Tuj1 (green), Hoechst (blue)
immunostaining. Lower panels: anti-BrdU (red)
and anti-Tuj1 (green) immunostaining. Explants
cultured in 100% E17 CSF in vitro maintained
tissue histology similar to embryo in vivo. Survival
and proliferation of explants cultured with E17
CSF indicated by immunoreactivity for PH3
along the ventricular surface, BrdU incorporation
in the ventricular zone, and Tuj1-positive-staining
neurons in the developing cortical plate.
(D) E16 explants cultured in 100% E13, E17, P6,
or adult CSF for 24 hr were immunostained with
anti-PH3 (see Figure S2C). Quantification of total
PH3-positive-staining cells per 400 mm explant
showed that proliferating cells increased in
explants cultured with E17 CSF compared to
E13, P6, or adult CSF. Immuno-positive cells
are represented as mean ± SEM (E17 mean,
44.1 ± 1.43; E13 mean, 25 ± 4.2; P6 mean, 9.2
± 0.8; adult mean, 9.6 ± 0.9, n = 4; Kruskal-
Wallis; p < 0.005).
(E) Quantification of ventricular PH3-staining cells
in explants (D). PH3-positive cells along the
ventricle were significantly increased in explants
cultured with E17 CSF compared to E13, P6, or
adult CSF (E17 mean, 32.3 ± 0.79; E13 mean,
12.8 ± 3.9; P6 mean, 4.9 ± 1.0; adult mean, 6.9 ±
0.73; n = 4; Kruskal-Wallis; p < 0.01).
(F) E16 explants (D) immunostained with anti-
Vimentin 4A4 (see Figure S2C) were quantified.
Vimentin 4A4-positive cells were significantly
increased in explants cultured with E17 CSF
compared to E13, P6, or adult CSF (E17 mean, 37.1 ± 1.4; E13 mean, 14.9 ± 1.9; P6 mean, 6.1 ± 1.05; adult mean, 7.3 ± 0.6; n = 4; Kruskal-Wallis; p < 0.005).
(G) Left panel: E16 explants cultured in control E17 CSF or E17 CSFwith Igf2 neutralizing antibody (Igf2 NAb), immunostained with anti-Vimentin 4A4 andHoechst
(E17 controlmean, 28.8 ± 4.3; E17 IGF2NAbmean, 13.9 ± 2.0; n = 4;Mann-Whitney; p < 0.05). Vimentin 4A4-positive cells decreased in explants culturedwith E17
CSF plus Igf2 NAb compared to control. Right panels: representative images of explants quantified in left panels.
(H) Primary neurospheres derived fromE14 cortexwere grown in 20%artificial (A), E14, E17, P6, or adult CSF for 10 days in vitro (DIV). E17CSF generated themost
spheres/cm2 (E17 mean, 274 ± 8.0; E14 mean, 77 ± 7.0; P6 mean, 110 ± 17.5; adult mean, 81 ± 8.8; n = 3; ANOVA; p < 0.005). See also Figure S2.
(I) Neurospheres derived from adult rat SVZ were cultured in artificial (A)CSF, Igf2 (20 ng/ml), E17 CSF, or adult rat CSF for 10DIV. Igf2, E17 CSF, and adult CSF
supported the growth andmaintenance of adult neurospheres (ACSF, 4.76 ± 0.67; Igf2, 17.3 ± 3.2; E17 CSF, 101.7 ± 15.8; adult CSF, 67.8 ± 12.6; Kruskal-Wallis,
Igf2 versus E17 CSF, p < 0.05; E17 CSF versus adult CSF, N.S.; n = 3).
See also Figure S2 and Tables S2 and S3.
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The CSF Instructs Cortical Progenitor ProliferationBy comparing rat CSF from several ages, we determined that
the effects of CSF on survival and proliferation are strikingly age
dependent and mimicked the temporal profile of CSF-Igf2
expression (Figure 3C). E17 CSF (near the middle of neurogene-
sis) maintained the healthiest explants and produced the
maximal increase in the frequency of PH3-labeled proliferating
cells in E16 cortical explants compared to explants cultured
with E13 (early in neurogenesis), P6, or adult CSF (Figures 4D,
4E, S2C, and data not shown). Many mitotic cells were identified898 Neuron 69, 893–905, March 10, 2011 ª2011 Elsevier Inc.as proliferating neuroepithelial progenitor cells by their immuno-
reactivity for phospho-Vimentin (4A4; Figures 4F and S2C). In
contrast, no differences were seen in Tbr2-positive basal
progenitors, which do not contact the CSF directly (data not
shown). Together, these data suggest that age-dependent
differences in CSF signals are both supportive and instructive
for neuroepithelial precursor proliferation in the developing
cortex. The CSF effects may be specific to neuroepithelial
progenitors, which contact the ventricle through the apical
Neuron
The CSF Instructs Cortical Progenitor Proliferationcomplex, without affecting the intermediate progenitors of
the SVZ.
We tested directly whether CSF-borne Igf2 was necessary to
explain the effects of age-specific CSF on rat cortical explants.
The frequency of proliferating cells declined in explants grown
in E17 CSF in the presence of Igf2 neutralizing antibodies
(Igf2 Nab; Figure 4G). Igf2 neutralization with Igf2 NAb did not
interfere with Igf1 levels in CSF compared to control as assayed
by ELISA (data not shown). While Igf signaling is known to
promote neuronal survival (Popken et al., 2004), we did not
observe differences in ventricular progenitor cell survival in these
explant experiments (data not shown), suggesting that Igf
actions on neural cell survival likely depends on the cell type,
developmental stage, and microenvironment. These data
confirm the important role for CSF borne Igf2 in regulating cere-
bral cortical progenitor cells but do not rule out roles of other CSF
borne factors as well.
CSF Influence on Isolated Neural Stem Cells
Requires Igf Signaling
Neural stem cells cultured as neurospheres confirmed the age-
dependent capacity of CSF to maintain neural stem cells
(Reynolds and Weiss, 1996) and provided additional evidence
suggesting that Igf2-mediated signaling is an essential determi-
nant of CSF activity on neural stem cells. CSF from any age sup-
ported the proliferation and maintenance of isolated cortical
stem cells cultured as primary or secondary neurospheres (Fig-
ure 4H and data not shown; Vescovi et al., 1993). However, E17
CSFwasmaximally effective in generating increased numbers of
neurospheres, larger neurospheres, and maintained neuro-
spheres even in long-term cultures for up to 44 days in vitro
(Figures 4H, S2D–S2G, and data not shown). Neurospheres
grown in CSF retained responsiveness to Fgf2 and Egf, indi-
cating that the CSF maintains stem cells in an uncommitted
fate (Figure S2H). CSF generated neurospheres from adult
SVZ precursors as well (Figure 4I). Consistent with these obser-
vations and our explant studies, the Igf1R inhibitor picropodo-
phyllin blocked the formation of spheres in the presence of E17
CSF (data not shown). Our data suggest that the choroid plexus
is the most prominent source of Igf2 in CSF (Figures 3 and S3A).
Accordingly, media conditioned with E17 choroid plexus
provided enhanced support for neurosphere formation com-
pared tomedia conditionedwith embryonic cortex, adult choroid
plexus, or adult brain (Table S3), demonstrating that one or more
factors actively secreted from the embryonic choroid plexus,
including potentially Igf2, is sufficient for stem cell growth and
maintenance. Thus, distinct factors secreted by the choroid
plexus into the embryonic CSF, including Igf2, confer E17 CSF
with an age-associated advantage to stimulate and maintain
neural stem cell proliferation, and Igf signaling is likely one
pathway that promotes this process.
Genetic Inactivation of Igf Signaling Impairs
Brain Development
Mouse explant experiments confirmed a requirement for Igf
signaling in the proliferation of progenitor cells. Mouse embry-
onic CSF supported the survival and proliferation of mouse
cortical progenitors (C57BL/6 explants: 20% ACSF in NBMmean, 7.4 ± 0.2; 20% E16.5 CSF in NBM mean, 14.1 ± 1.4;
Mann-Whitney; p < 0.01; n = 3), and purified Igf2 in 20% ACSF
in NBM stimulated cortical progenitor proliferation (Figure 5A).
When the Igf1R was genetically inactivated in cortical progeni-
tors (Igf1RloxP/loxP/NestinCre+/) (Liu et al., 2009), wild-type
CSF no longer stimulated cortical progenitor proliferation
(ACSF, 17.6 ± 2.9; E16.5 CSF, 16.4 ± 3.0; Mann-Whitney; N.S.;
n = 3). Importantly, CSF obtained from Igf2/ mice failed to
stimulate progenitor proliferation in wild-type explants
compared to control (Figure 5B), suggesting that Igf2 in its native
CSF environment stimulates proliferation of progenitor cells
during cerebral cortical development.
As expected for the roles we have shown for Igf2 in regulating
proliferation, we found that Igf2-deficiency reduced brain size
(Figure 5C). Igf2/ brain weight decreased by 24% at P8
compared to controls (Figure 5D). Accordingly, the overall
cortical perimeter and surface area were reduced in Igf2/
brains compared to controls as well (Figures 5E–5G). Profound
defects in somatic size couple to brain size (Purves, 1988). As
previously reported (DeChiara et al., 1991; Baker et al., 1993),
Igf2/ body weight was reduced compared to control (mean
body weight (g) at P8: Igf2+/+, 5.6 ± 0.01; Igf2/, 2.8 ± 0.1;
Mann-Whitney; p < 0.0001; n = 11), suggesting that Igf2 may
be a secreted factor that scales brain size to body size. Consis-
tent with the mouse CSF Igf2 expression pattern that is signifi-
cantly increased during later embryonic development (Fig-
ure S3B), blunting Igf2 expression markedly reduced the
proliferating progenitor cells at E16.5 compared to controls
(PH3-positive cells/100 mm VZ ± SEM at E16.5: Igf2+/+, 2.5 ±
0.3; Igf2/, 1.7 ± 0.1; Mann-Whitney; p < 0.05; n = 5). NeuN-
and late-born Cux1-staining neurons were reduced in Igf2/
mice (Figure 5H and data not shown), confirming that Igf2
contributes to cortical progenitor proliferation and to late stages
of neurogenesis. Taken together, our genetic experiments
support a model in which the apical complex localizes Igf
signaling in progenitors by ensuring the apical, ventricular local-
ization of the Igf1R. In this manner, the apical complex couples
cell autonomous and extracellular signals to the regulation of
cortical development.
Glioblastoma CSF Expresses High Igf2
Our data, together with recent findings implicating Igf signaling in
the maintenance of adult neural stem cells (Llorens-Martı´n et al.,
2010), raised the possibility that abnormalities of the CSFmay be
relevant to conditions showing abnormal proliferation, including
in glioblastoma multiforme (GBM), a malignant astrocytic brain
tumor. Igf-PI3K-Akt signaling has been implicated as a key regu-
lator of gliomagenesis (Louis, 2006; Soroceanu et al., 2007), and
mutations in PTEN are commonly found in patients with GBM
(Louis, 2006). We analyzed Igf2 concentration in a panel of 56
human GBM patient CSF samples collected from 21 individuals
representing the full range of disease progression and 8 disease-
free controls and found that CSF from GBM patients contained
significantly more Igf2 than CSF from disease-free controls
(Igf2 concentration expressed asmean ± SEM for GBM patients,
340.4 ± 12.9 ng/ml; n = 56; disease-free controls, 222.9 ±
41.5 ng/ml; n = 8; Mann-Whitney, p < 0.01). Three GBM samples
containing the highest Igf2 concentrations (605.8 ng/ml,Neuron 69, 893–905, March 10, 2011 ª2011 Elsevier Inc. 899
Figure 5. CSF Igf2 Regulates Progenitor
Proliferation and Brain Size
(A) Left panels: E15.5 C57BL/6 explants cultured
in NBM supplemented with 20% ACSF or
ACSF/Igf2. Igf2 stimulated the proliferation of
PH3-positive cortical progenitor cells (C57BL/6
explants: ACSF mean, 7.4 ± 0.2; Igf2 mean, 11.2
± 0.3; Mann-Whitney, p < 0.05; n = 3). Right
panels: representative images of explants quanti-
fied in left panels.
(B) E15.5 C57BL/6 explants cultured in NBM sup-
plemented with 20% E16.5 wild-type or Igf2/
CSF. Igf2-deficient CSF failed to stimulate progen-
itor cell proliferation compared to control
(Igf2+/+,17.9 ± 0.8; Igf2/ CSF, 11.4 ± 1.0;
Mann-Whitney; p < 0.06; n = 3 and n = 4, respec-
tively).
(C) Representative images of P8 Igf2/ and
control brains.
(D) Igf2deficiency reducedP8brainweight (Igf2+/+,
0.34 g ± 0.008; Igf2/, 0.26 g ± 0.004;Mann-Whit-
ney, p < 0.0001, n = 11).
(E) Igf2 deficiency reduced P8 cortical perimeter
(Igf2+/+, 30.9 mm ± 0.01; Igf2/, 26.4 mm ± 0.1;
Mann-Whitney, p < 0.0001, n = 11).
(F) Igf2 deficiency reduced P8 cortical surface area
(Igf2+/+, 13.0mm2 ± 0.1; Igf2/, 9.4 mm2 ± 0.1;
Mann-Whitney, p < 0.0001, n = 11).
(G)H&E staining of Igf2/ and control brains at P8.
(H) Left panels: Igf2/ brains have reduced
numbers of upper layer neurons marked by Cux1
(total Cux1-positive staining cells in equally sized
cortical columns expressed as mean ± SEM:
Igf2+/+, 157 ± 1.5; Igf2/, 131.3 ± 3.3; t test,
p < 0.005, n = 3). Right panels: representative
images of Igf2/ and control brains quantified in
left panels.
See also Figure S3.
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The CSF Instructs Cortical Progenitor Proliferation502.8 ng/ml, and 468.7ng/ml) came from patients with advanced
disease (Figure 6A and Table 1). By contrast, the three patients
with the lowest levels of Igf2 (142.1 ng/ml, 145.4 ng/ml, and
153.9 ng/ml) all had early or stable glioma (Figure 6A andTable 1).
Similar to rodent ventricular CSF, human lumbar CSF stimulated
cortical progenitor cell proliferation in our explant assay, with
CSF from GBM patients causing greater proliferation than CSF
from disease-free controls (Figure 6B). Moreover, human GBM
patient CSF neutralized with Igf2 antibodies failed to stimulate
the proliferation of progenitor cells (Figure 6B; Igf2 concentration
following NAb absorption, GBM1(PBS): 605.8 ng/ml; GBM1
(NAb), 45.6 ng/ml; GBM2(PBS), 502.8 ng/ml; GBM2(NAb),
218.3 ng/ml; GBM3(PBS), 468.7 ng/ml; GBM3(NAb),
248.8 ng/ml). Taken together, these data suggest that beyond
embryonic brain development, CSF-Igf2, in particular, is a poten-
tial mediator of GBM pathology and that the CSF mechanisms
that normally regulate neural stem cells are misregulated
in GBM.
CSF-Mediated Long-Range Distribution
of Additional Secreted Factors
Whereas our studies suggest an important role for Igf2 in control-
ling proliferation in late stages of neurogenesis and potentially900 Neuron 69, 893–905, March 10, 2011 ª2011 Elsevier Inc.postnatally, they do not rule out the presence of other secreted
factors that may act at long ranges via the CSF, and so we per-
formed functional screening tests for several other families of
factors. The CSF contained Wnt signaling activity (Zhou et al.,
2006), based upon phosphorylation of LRP6, a Wnt coreceptor
in response to CSF exposure (Figure 7A). Several Wnt ligands
were expressed along the ventricular surface and in the choroid
plexus (Figure 7B and data not shown; Grove et al., 1998). Friz-
zled (Fz) receptors, which bind LRP6 to transduce Wnt signals,
showed enhanced expression in ventricular progenitors (Fig-
ure 7B and data not shown; Zhou et al., 2006), suggesting that
CSF may distribute Wnts to precursors throughout the ventric-
ular surface. Additional signaling activities that influence cortical
development were also found in the CSF, with responsive cells
seen broadly in the ventricular zone. There were dynamic levels
of bone morphogenetic protein (Bmp) activity in the CSF during
different stages of cortical development (Figure 7C). Using
a luciferase-based assay in which overall Bmp activity can be
quantified between 0.1 and 100 ng/ml (data not shown), we
found that Bmp activity in the CSF decreased during embryo-
genesis and peaked in adulthood (Figure 7C). CSF-borne Bmp
activity may be responsible for stimulating progenitors widely
throughout the cortical ventricular zone in vivo, based on
Figure 6. Glioblastoma CSF Igf2 Supports Progenitor Proliferation
(A) MRI scans from subjects with low and high CSF Igf2 levels. Gadolinium-
enhanced T1-weighted (T1-Gad) MRI sequence delineated the contrast-
enhanced portion of the tumor where tumor angiogenesis developed. Fluid
attenuation inversion recovery (FLAIR) images included area of nonvascular-
ized and invasive tumor (Macdonald et al., 1990).
(B) Twenty percent humanGBMCSF in NBM stimulated PH3-positive proliferating
cells compared to an average of three disease-free control CSFs in E16 rat
explants (control = 16.0 ± 4.1 [n = 3]; GBM1 = 32.3 ± 4.3 [n = 4]; GBM2 = 23.0 ±
2.8 [n = 5]; GBM3 = 23.4 ± 3.8 [n = 4]; Mann-Whitney, p < 0.05). Igf2(NAb) inhibited
GBMCSF-stimulated progenitor proliferation (GBM1 = 13.5 ± 2.9 [n = 4]; GBM2 =
9.0 ± 2.7 [n = 4]; GBM3 = 13.0 ± 1.5 [n = 3]; Mann-Whitney, p < 0.05). CSF Igf2
concentration before and after Igf2 NAb absorption: GBM1(PBS) = 605.8 ng/ml;
GBM1(NAb) = 45.6 ng/ml; GBM2(PBS) = 502.8 ng/ml; GBM2(NAb) = 218.3 ng/ml;
BM3(PBS) = 468.7 ng/ml; GBM3(NAb) = 248.8 ng/ml).
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in the absence of any known Bmp ligands localizing to the
ventricular zone (Shimogori et al., 2004), whereas Bmps 2, 4, 5,
and 7 are expressed in embryonic and adult choroid plexus (Fig-
ure 7E; He´bert et al., 2002; Shimogori et al., 2004). Moreover,
growth and differentiation factors 3 and 8 (GDF3 and GDF8),
both members of the TGF-b superfamily of proteins that can
influence Bmp signaling (Levine and Brivanlou, 2006) were found
in our MS analyses of CSF (data not shown), though we do not
consider our MS analysis to have recovered all potential smaller
ligands in the CSF. Retinoic acid (RA) (Haskell and LaMantia,
2005; Siegenthaler et al., 2009) activity in CSF also varied over
the course of cortical development (Figure 7F). A luciferase-
based assay that quantifies RA activity ranging between 109
and 106M (data not shown) revealed that RA activity in CSF
peaked early and decreased in adulthood (Figure 7F). In parallel,
RA responsive cortical progenitors localized to the developing
ventricular zone (Figure 7G). Similar to Wnts and Bmps, RA is
most likely released into CSF since RA synthetic and catabolic
enzymes were expressed in the choroid plexus (Figure 7H) and
meninges (data not shown). Thus, CSF shows bioavailability of
a wide range of activities known to regulate neurogenesis,
patterning, and neuronal survival in the cerebral cortex and
throughout the CNS.
DISCUSSION
We show that the CSF plays an essential, active role in distrib-
uting signals in the central nervous system. The key findings of
our study are (1) the apical complex is essential for the apical
localization of Igf1R; (2) Pten deficiency in the Pals1 background
results in an almost normally sized brain; (3) CSF Igf2 binds to the
apical domain of cortical progenitor cells, stimulating their prolif-
eration in an age-dependent manner; (4) Igf2 is upregulated in
GBM patient CSF, contributing to the range of proliferative activ-
ities of GBM patient CSF; and (5) the CSF provides an adaptive
library of secreted factors throughout life. Thedynamic regulation
of several potent modulators of neural stem cells reinforces the
central relationship between local signaling at the apical surface
via ligands delivered by the CSF during cortical neurogenesis.
Asymmetric Growth Factor-Based Signaling
It has been suggested that asymmetry of signaling at the apical
versus basolateral aspect of cortical progenitors regulates
progenitor progress through the cell cycle (Bultje et al., 2009;
Sun et al., 2005). The basolateral expansion of the Igf1R
signaling domain we report in Pten mutants suggests
potential links between asymmetric growth factor signaling and
proliferation. Although asymmetric localization of the EgfR in
cortical progenitors has previously been reported (Sun et al.,
2005), the ventricular enrichment of the Igf1R was not known
and raises the possibility that the apical enrichment of the
Igf1R along with other apical proteins confers a differential
responsiveness to mitogenic signals, akin to Notch signaling
(Bultje et al., 2009). Since Igfs are potent mitogens for cortical
progenitors (Hodge et al., 2004; Popken et al., 2004), one model
might suggest that inheritance of the apical complex promotes
progenitor fate by differentially concentrating Igf1R and itsNeuron 69, 893–905, March 10, 2011 ª2011 Elsevier Inc. 901
Table 1. Clinical Presentation of GBM Patients with Lowest and Highest CSF Igf2 Concentrations
Patient [Igf2] ng/ml
Clinical Presentation
Tumor size:
T1-Gad (cm2)
Tumor size:
FLAIR (cm2) Life Span
Low CSF Igf2 L1 142.1 7.14 6.46 Stable disease at follow-up; 3 weeks post-CSF collection
L2 145.4 8.50 54.12 Stable disease at follow-up; 3 weeks post-CSF collection
L3 153.9 5.94 20.5 Stable disease at follow-up; 5 weeks post-CSF collection
High CSF Igf2 H1 605.8 47.31 102.83 Deceased at 1 week post-CSF collection
H2 502.8 13.69 53.90 Deceased at 52 weeks post-CSF collection
H3 468.7 23.94 36.48 Deceased at 30 weeks post-CSF collection
Patientswith the lowest CSF Igf2 concentrations (L1–L3) had early or stable GBMdisease state, while patients with the highest CSF Igf2 concentrations
(H1–H3) had advanceddisease and aggressive tumor progression at time ofCSF collection. Tumor sizewas determined byMacdonald’s criteria, where
T1-Gad MRI sequence delineated the contrast-enhanced portion of tumor, and FLAIR images include areas of nonvascularized and invasive tumor
(Macdonald et al., 1990). High-CSF Igf2 patients had larger T1-Gad tumor sizes compared to low-CSF Igf2 patients (Mann-Whitney; p < 0.05; n=3).
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karya or at least a process (likely a cilium) in the ventricular
zone, causing these cells to remain in the cycling pool. The pres-
ence of proliferation-inducing factors in the CSF suggests that
withdrawal of the progenitor’s apical ventricular process may
be an important step in neuronal differentiation (Cappello et al.,
2006), by insulating progenitor cells from proliferative signals in
CSF, with vascular niches potentially supplying sources of
secreted factors for stem cells at other stages (Palmer et al.,
2000; Shen et al., 2004, 2008; Tavazoie et al., 2008).
Our data provides a new perspective on the production and
provision of Igf ligands, which are known to regulate stem cell
populations in the brain and other proliferative epithelia
(Bendall et al., 2007; Hodge et al., 2004; Liu et al., 2009; Popken
et al., 2004; Ye et al., 2004; Zhang and Lodish, 2004). In the E17
rat brain, the choroid plexus was the strongest source of Igf2,
though we cannot discount a contribution by the vasculature or
other cellular sources of Igf2 that may percolate into the CSF.
Indeed, both pericytes and endothelial cells express Igf2 (Dugas
et al., 2008), and Igfs from vascular tissue may have local effects
beyond apically mediated Igf1R signaling shown here. Thus,
locally derived Igf2 may play distinct roles at different develop-
mental time points and in different cellular contexts, and Igf
signalingmayalsobe influencedbyCSF Igf1and insulin.Although
Igf2 availability decreased in adult CSF (Figures 3C andS3B), Igf2
continued to be expressed in adult choroid plexus (data not
shown) and maintained adult neurospheres (Figure 4I), suggest-
ing that low levels of CSF Igf2 contribute to the maintenance of
adult neural stem cells. The aberrant increase in Igf2 in advanced
GBM patients reinforces the hypothesis that Igf signaling has an
influence on proliferation of cortical precursors. Our identification
of Igf2 regulation of neurogenesis and brain size complements
a literature in which Igf signaling is well known to influence body
and brain size (Baker et al., 1993; DeChiara et al., 1991; Purves,
1988), raising the intriguing possibility that Igf2 represents
a secreted factor that may scale brain size to body size.
Fluid-Based Signaling in the CNS and Beyond
The activity of growth promoting factors in the CSF and their
action on progenitors across the apical surface may be a model
for other epithelia including lung, gut, and vascular endothelia902 Neuron 69, 893–905, March 10, 2011 ª2011 Elsevier Inc.that develop in relation to extracellular fluids (Bendall et al.,
2007; Scadden, 2006). Extracellular fluid apparently regulates
the microenvironment of hematopoietic stem cells, where Igf
signaling regulates progenitor proliferation (Orkin and
Zon, 2008; Zhang and Lodish, 2004). The differential capacity
of Igf signaling to confer a proliferative advantage to stem cells
may be regulated in part by Igf’s interactions with binding
proteins or other secreted factors in the environment (Clem-
mons, 1997). Our experiments focused on the age-associated
effects of CSF on survival and proliferation across the cortical
ventricular zone. However, the distribution of CSF resident
proteins, as well as the flow of the CSF, may also influence ciliary
orientation andmaturing ependymal cell polarity (Mirzadeh et al.,
2010), which create activity gradients as has been shown for Slit
(Sawamoto et al., 2006).
If a major component of the stem cell niche reflects secreted
factors acting at long distances from their sources, modulation
of the proteomic composition of extracellular fluids may also
provide unexpected ways to regulate stem cell behavior in
health and disease. For example, while Igf2 activity peaked
in embryonic CSF, some CSF-borne Igf persisted in adulthood
(Figures 3, S3B, and data not shown). Igf2 and Igf1 in adult CSF
may contribute to the retention of neural stem cell properties in
the adult SVZ (Doetsch et al., 1999). Importantly, the regulation
of CSF growth factors may also extend to pathologic states.
Igf2 and other diffusible growth factors that drive neural progen-
itor proliferation during development are upregulated in some
GBM patients (Louis, 2006; Soroceanu et al., 2007), and GBM
patients have elevated Igf2 levels in their CSF. CSF Ab1–42 and
phosphorylated Tau levels were recently shown to assist in
Alzheimer’s disease diagnosis (De Meyer et al., 2010). Thus,
modulation of the proteomic composition of extracellular fluids
together with the integration of cell autonomous determinants of
self-renewal by the apical complex may ultimately provide unex-
pected ways to regulate stem cell behavior in health and disease.
EXPERIMENTAL PROCEDURES
Animals
Time pregnant Sprague-Dawley, C57BL/6, and Swiss Webster dams were
purchased from Charles River Laboratories and Taconic. Pals1loxP/loxP/
NestinCre+/, Pals1loxP/loxP/Emx1Cre+/, Igf1RloxP/loxP/NestinCre+/, and
Figure 7. The CSF Proteome Coordinates
Multiple Signaling Pathways that Regulate
Brain Development
(A) Lysates of cortical cells were left untreated or
treated with 20% ACSF or E17 CSF and 10%
Wnt3a conditioned medium or its control medium
for 2 hr and subjected to immunoblotting with the
P-LRP6 or LRP6 antibodies.
(B) In situ hybridization forWnt5a and Fz1 inmouse
E14.5 cortex.
(C) Bmp activity was measured in E14, E17, and
adult rat CSF as luciferase signal in a clonally
derived Bmp-sensitive cell line. Responses were
compared to linear responses generated in the
same cell line by pure ligand (Bmp4; data not
shown). Bmp activity levels varied with age and
were statistically significant between E17 and
adult (ANOVA, p < 0.001; n = 4).
(D) Toppanel: expressionandnuclear localizationof
phospho-Smad (P-SMAD) 1/5/8 in E14 rat cortical
ventricular cells. Bottom panel: arrow points to
expression and nuclear localization of P-SMAD1/
5/8 in E16.5 mouse cortical ventricular cells.
(E) qPCRmeasurement ofBmps2, 4, 5, and7 in the
E16, E18, P0, and adult rat choroid plexus (CP).
(F) Quantification of RA activity in E14, E17, and
adult rat CSF. RA activity declined, based on
comparison of CSF activation of anRA responsive,
clonally derived cell line with response to RA at
known concentrations, frommidgestation through
adulthood (ANOVA, p = 0.07; n = 4).
(G) RA responsive progenitor cells at the cortical
ventricular zone from an E16.5 DR5-RARE trans-
genic mouse (LaMantia et al., 1993).
(H) qPCR of Raldh1, 2, 3, and Rdh10, in rat CP.
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The CSF Instructs Cortical Progenitor ProliferationGFAP:Igf_1Tg mice were obtained from heterozygous breedings, and
PtenloxP/+/Pals1loxP/+/Emx1Cre+/, and PtenloxP/loxP/Pals1loxP/+/Emx1Cre+/
mice were obtained from PtenloxP/+/Pals1loxP/loxP/Emx1Cre+/ and
PtenloxP/loxP/Emx1Cre/ crosses (Groszer et al., 2001; Kim et al., 2010; Liu
et al., 2009; Ye et al., 2004). Igf2/ and control CSF was collected from
embryos obtained from homozygous breedings. Igf2/ and control P8 brains
were obtained from homozygous crosses or paternal heterozygotes mated
with homozygous knockouts (DeChiara et al., 1991). All animal experimenta-
tion was carried out under protocols approved by the IACUCs of Harvard
Medical School, Children’s Hospital Boston, and UNC-Chapel Hill.
Antibodies
The following antibodies were purchased: Ctip2, Igf2 (for EM), Tbr2 (Abcam);
BrdU (AbD Serotec); Ki67 (Abnova); Vimentin 4A4 (Assay Designs); Pax6
(Developmental Studies Hybridoma Bank); b-catenin, Cdc42 (BD Biosci-
ences); AKT, phospho-AKT, Igf1R, phospho-Igf1R, CC3, and phospho-S6rp
(Cell Signaling); GLAST (Chemicon); Tuj1 (Covance); HRP conjugated anti-
Transferrin (Immunology Consultants Laboratory, Inc.); Igf2 (NAb; Millipore);
Cux1, Igf2 (for WB) (Santa Cruz Biotechnology); and phospho-Histone H3
(Upstate). Tbr1 was a kind gift of R. Hevner.
CSF Isolation
Embryonic rodent CSF, isolated as described (Zappaterra et al., 2007), was
kept on ice during collection, centrifuged at 10,000 3 g at 4C for 10 min.,
and stored at 80C. Human GBM and disease-free CSF samples were
collected by lumbar puncture from patients undergoing clinical evaluation.
The 56 GBM samples tested were obtained from 21 individuals representing
the full-range of disease progression. The samples used in analyses of highest
and lowest CSF Igf2 concentration were obtained from distinct individuals. All
research was approved by the IRBs at BIDMC and Children’s Hospital Boston.Cortical Explants
The telencephalic wall was dissected onto polycarbonate membranes
(Whatman; 13 mm, 8.0 mm) and cultured for 24 hr as described in text. Artificial
(A)CSF (NaCl 119 mM, KCl 2.5 mM, NaHCO3 26 mM, NaH2PO4 1 mM,
glucose 11 mM, MgCl2 2 mM, CaCl2 2.8 mM) was supplemented with Igf2
(2 ng/ml; US Biologicals) as indicated. Igf2 NAb antibody was incubated
with E17 CSF for 1 hr at 4C. Explants were pulsed with BrdU for 30 min
and fixed (60% methanol, 30% chloroform, and 10% acetic acid; 10 min).
For in vivo BrdU labeling, pregnant dams were administered a 3 hr BrdU
(60 mg/kg) pulse. Tissue was paraffin sectioned (5 mm).SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, three tables, and Supple-
mental Experimental Procedures and can be found with this article online at
doi:10.1016/j.neuron.2011.01.023.
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